id,gene_symbol,protein_name,tier,priority_score,pdb_count_total,alphafold_mean_pLDDT,has_cryoEM,has_activation_state_pdb_pair,activation_state_pdb_active,activation_state_pdb_inactive,drug_count_approved,has_known_aptamer,aptamer_count_pubmed,aptamer_pmids,in_cev_map,opentargets_top_disease_name,opentargets_top_disease_score
P12263,,,Tier 1,0.9,7,63.59,1,0,,,,0,0,,0,,
Q12879,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",Tier 1,0.88,37,60.84,1,0,,,,0,0,,0,Landau-Kleffner syndrome,0.8407159711916629
Q9UJA9,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Tier 1,0.87,1,88.12,0,0,,,,0,0,,0,neurodegenerative disease,0.33211724272317855
Q5T848,GPR158,Metabotropic glycine receptor,Tier 1,0.839,6,58.03,1,0,,,,0,0,,0,diverticular disease,0.4384404783771627
P0DSE2,TRB,M1-specific T cell receptor beta chain,Tier 1,0.83,5,90.12,1,0,,,,0,0,,0,,
Q31135,H2-Ab1,,Tier 1,0.83,12,85.12,0,0,,,,0,0,,0,,
Q9NS82,SLC7A10,Asc-type amino acid transporter 1,Tier 1,0.803,4,83.38,1,0,,,,0,0,,0,asthma,0.5295411410172121
O60895,RAMP2,Receptor activity-modifying protein 2,Tier 1,0.802,10,80.94,1,0,,,,0,0,,0,diabetes mellitus,0.4219370007650345
P01909,HLA-DQA1,"HLA class II histocompatibility antigen, DQ alpha 1 chain",Tier 1,0.792,27,87.94,1,0,,,,0,0,,0,Pleural Mesothelioma,0.1228600330569846
Q13639,,,Tier 1,0.781,3,80.88,1,0,,,,0,0,,0,schizophrenia,0.6060830827022777
O15393,,,Tier 1,0.775,31,79.38,1,0,,,,0,0,,0,COVID-19,0.6157541390484623
A6ND01,IZUMO1R,Sperm-egg fusion protein Juno,Tier 1,0.773,7,87.38,0,0,,,,0,0,,0,placental retention,0.23306495563589497
A0A5H2UYS3,HLA-A,,Tier 1,0.77,20,85.25,0,0,,,,0,0,,0,,
P29460,IL12B,Interleukin-12 subunit beta,Tier 1,0.769,20,91.12,1,0,,,,0,0,,0,psoriasis,0.7914863943708039
P98073,,,Tier 1,0.761,14,81.5,1,0,,,,0,0,,0,congenital enteropathy due to enteropeptidase deficiency,0.7102613227574134
O75762,TRPA1,Transient receptor potential cation channel subfamily A member 1,Tier 1,0.76,17,81.94,1,0,,,,0,0,,0,familial episodic pain syndrome with predominantly upper body involvement,0.6615353934604322
O43614,,,Tier 1,0.75,11,78.94,1,0,,,,0,0,,0,insomnia,0.5988748728311054
P16471,PRLR,Prolactin receptor,Tier 1,0.747,12,61.03,0,0,,,,0,0,,0,familial hyperprolactinemia,0.5718636087471152
P01563,,,Tier 1,0.744,13,85.06,0,0,,,,0,0,,0,renal cell carcinoma,0.3938654263610389
O15245,SLC22A1,Solute carrier family 22 member 1,Tier 1,0.744,16,84.25,1,0,,,,0,0,,0,coronary artery disease,0.5384890077265535
Q8N158,GPC2,Glypican-2,Tier 1,0.744,2,79.06,1,0,,,,0,0,,0,COVID-19,0.5409211817593593
O43526,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,Tier 1,0.744,24,58.19,1,0,,,,0,0,,0,Benign familial neonatal seizures,0.8423358217314708
P40879,SLC26A3,Chloride anion exchanger,Tier 1,0.742,13,85.06,1,0,,,,0,0,,0,congenital secretory chloride diarrhea 1,0.8189631913308207
D7RIG0,HLA-DRB1,,Tier 1,0.74,10,84.94,1,0,,,,0,0,,0,,
A0A1B0GX56,TRDV1,T cell receptor delta variable 1,Tier 1,0.737,7,90.69,1,0,,,,0,0,,0,colorectal carcinoma,0.07391597093694036
Q14028,CNGB1,Cyclic nucleotide-gated channel beta-1,Tier 1,0.734,11,57.66,1,0,,,,0,0,,0,retinitis pigmentosa,0.7931901344765326
P41145,OPRK1,Kappa-type opioid receptor,Tier 1,0.725,28,79.5,1,0,,,,0,0,,0,alcohol dependence,0.6106562988740131
P23416,GLRA2,Glycine receptor subunit alpha-2,Tier 1,0.723,13,83.81,1,0,,,,0,0,,0,"intellectual developmental disorder, X-linked, syndromic, Pilorge type",0.7805605973560554
Q16878,CDO1,Cysteine dioxygenase type 1,Tier 1,0.72,17,93.62,0,0,,,,0,0,,0,adolescent idiopathic scoliosis,0.3105991982786747
P29033,GJB2,Gap junction beta-2 protein,Tier 1,0.72,24,86.19,1,0,,,,0,0,,0,palmoplantar keratoderma-deafness syndrome,0.8149616697051898
B7Z8K6,TRDC,T cell receptor delta constant,Tier 1,0.72,12,81.38,1,0,,,,0,0,,0,,
Q12918,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Tier 1,0.719,3,81.0,0,0,,,,0,0,,0,sensory perception of smell,0.287724180593876
A0A0B4J271,TRAV12-3,T cell receptor alpha variable 12-3,Tier 1,0.715,12,92.56,1,0,,,,0,0,,0,ulcerative colitis,0.003139210371371825
Q695T7,SLC6A19,Sodium-dependent neutral amino acid transporter B(0)AT1,Tier 1,0.715,19,90.0,1,0,,,,0,0,,0,Hartnup disease,0.8464240093600148
Q99574,SERPINI1,Neuroserpin,Tier 1,0.712,3,88.12,0,0,,,,0,0,,0,familial encephalopathy with neuroserpin inclusion bodies,0.7162803151916303
A0A583ZB34,,,Tier 1,0.71,9,84.38,0,0,,,,0,0,,0,,
P49019,HCAR3,Hydroxycarboxylic acid receptor 3,Tier 1,0.709,11,79.19,1,0,,,,0,0,,0,Oral ulcer,0.3943093179045574
O15342,ATP6V0E1,V-type proton ATPase subunit e 1,Tier 1,0.708,9,92.88,1,0,,,,0,0,,0,multiple myeloma,0.18220286553988743
Q9BXJ8,TMEM120A,Transmembrane protein 120A,Tier 1,0.706,5,89.25,1,0,,,,0,0,,0,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,0.1609725589293368
P14555,PLA2G2A,"Phospholipase A2, membrane associated",Tier 1,0.7,17,91.0,0,0,,,,0,0,,0,familial colorectal cancer,0.3326218692162316
Q5Y7D3,HLA-DQB1,,Tier 1,0.7,6,85.31,0,0,,,,0,0,,0,,
P22888,LHCGR,Lutropin-choriogonadotropic hormone receptor,Tier 1,0.698,4,80.12,1,0,,,,0,0,,0,"Leydig cell hypoplasia, type 1",0.783461117057047
O43570,CA12,Carbonic anhydrase 12,Tier 1,0.695,40,87.81,0,0,,,,0,0,,0,isolated hyperchlorhidrosis,0.6794515382695604
Q07699,SCN1B,Sodium channel regulatory subunit beta-1,Tier 1,0.695,36,87.06,1,0,,,,0,0,,0,Generalized epilepsy with febrile seizures-plus,0.7638796221342504
P30989,NTSR1,Neurotensin receptor type 1,Tier 1,0.695,24,79.62,1,0,,,,0,0,,0,Cough,0.31206841983343936
Q96QV1,HHIP,Hedgehog-interacting protein,Tier 1,0.692,11,79.75,0,0,,,,0,0,,0,Abnormality of the skeletal system,0.5195282784554633
P04435,TRBV7-9,T cell receptor beta variable 7-9,Tier 1,0.691,2,90.06,0,0,,,,0,0,,0,neoplasm,0.11454334012562349
Q02083,NAAA,N-acylethanolamine-hydrolyzing acid amidase,Tier 1,0.69,2,92.25,0,0,,,,0,0,,0,abscess,0.2726858643799341
Q15788,NCOA1,Nuclear receptor coactivator 1,Tier 1,0.69,100,46.72,0,0,,,,0,0,,0,neurodegenerative disease,0.48697450901885614
A0A9P1NJI6,,,Tier 1,0.69,6,,0,0,,,,0,0,,0,,